Home > Insider Trading > Filing (0001735276-19-000096)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178670	Alnylam Pharmaceuticals Inc.	ALNY	Pharmaceutical Preparations (2834)	770602661

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226295	A Phillip Sharp	675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-11-18	15,000	$16.43	250,633	No	4	M	Direct
Common Stock	Disposition	2019-11-18	5,559	$91.17	245,074	No	4	S	Direct
Common Stock	Disposition	2019-11-18	8,631	$91.97	236,443	No	4	S	Direct
Common Stock	Disposition	2019-11-18	810	$92.66	235,633	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2019-11-18	15,000	$0.00	15,000	$16.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-12-10	2019-12-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	31,266	Indirect	by Trust

Footnotes

The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019. The 15,000 options exercised and sold by the reporting person were due to expire on December 9, 2019.
Sale prices ranged from $90.50 to $91.49.
Sale prices ranged from $91.50 to $92.48.
Sale prices ranged from $92.53 to $92.74.
Includes shares of ALNY common stock held in trusts for the benefit of the children of Dr. Sharp, of which the spouse of Dr. Sharp and children are the trustees.